 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Kewalramani Reshma
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2018-10-08 Sale | 2018-10-09 4:50 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 2,305 | $186.95 | $430,920 | 1,909 (Direct) | View |
| 2019-02-19 Sale | 2019-02-21 4:22 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 1,488 | $186.94 | $278,163 | 13,736 (Direct) | View |
| 2019-05-15 Sale | 2019-05-17 4:21 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 241 | $165.41 | $39,864 | 13,736 (Direct) | View |
| 2019-10-22 Sale | 2019-10-24 7:18 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 638 | $189 | $120,582 | 13,098 (Direct) | View |
| 2019-10-30 Sale | 2019-10-31 4:36 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 3,057 | $199 | $608,343 | 13,098 (Direct) | View |
| 2019-11-08 Sale | 2019-11-13 4:08 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 509 | $199 | $101,291 | 13,098 (Direct) | View |
| 2019-11-15 Sale | 2019-11-19 4:11 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 61 | $205.95 | $12,563 | 13,098 (Direct) | View |
| 2019-11-25 Sale | 2019-11-26 4:12 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 4,692 | $219.37 | $1,029,284 | 13,098 (Direct) | View |
| 2020-02-05 Sale | 2020-02-07 4:14 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 2,074 | $239.44 | $496,600 | 35,285 (Direct) | View |
| 2020-02-17 Sale | 2020-02-19 4:33 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 1,183 | $243.51 | $288,070 | 33,158 (Direct) | View |
| 2020-02-24 Sale | 2020-02-26 4:32 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 3,634 | $233.45 | $848,371 | 26,626 (Direct) | View |
| 2020-05-06 Sale | 2020-05-08 4:19 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO | 2,074 | $272.85 | $565,882 | 26,626 (Direct) | View |
| 2020-05-15 Sale | 2020-05-19 4:35 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO | 99 | $284.17 | $28,132 | 26,626 (Direct) | View |
| 2020-08-06 Sale | 2020-08-10 4:19 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO | 2,073 | $271.2 | $562,205 | 26,626 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-02-06 Option Award | 2019-02-08 4:39 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 3,516 | $0 | 25,026 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 4:39 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 9,799 | $0 | 25,026 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 4:39 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 25,026 | $187.53 | 25,026 (Direct) | View |
| 2019-10-30 Exercise | 2019-10-31 4:36 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 3,057 | $155.57 | 13,098 (Direct) | View |
| 2019-10-30 Exercise | 2019-10-31 4:36 pm | N/A 2028-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 3,057 | $155.57 | 13,098 (Direct) | View |
| 2019-11-08 Exercise | 2019-11-13 4:08 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 509 | $155.57 | 13,098 (Direct) | View |
| 2019-11-08 Exercise | 2019-11-13 4:08 pm | N/A 2028-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 509 | $155.57 | 13,098 (Direct) | View |
| 2019-11-25 Exercise | 2019-11-26 4:12 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 4,692 | $187.53 | 13,098 (Direct) | View |
| 2019-11-25 Exercise | 2019-11-26 4:12 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 4,692 | $187.53 | 13,098 (Direct) | View |
| 2020-02-05 Option Award | 2020-02-07 4:14 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 9,800 | $0 | 35,285 (Direct) | View |
| 2020-02-05 Option Award | 2020-02-07 4:14 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 12,387 | $0 | 35,285 (Direct) | View |
| 2020-02-05 Exercise | 2020-02-07 4:14 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 1,564 | $187.53 | 35,285 (Direct) | View |
| 2020-02-05 Exercise | 2020-02-07 4:14 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 510 | $155.57 | 35,285 (Direct) | View |
| 2020-02-05 Exercise | 2020-02-07 4:14 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 1,564 | $187.53 | 35,285 (Direct) | View |
| 2020-02-05 Exercise | 2020-02-07 4:14 pm | N/A 2028-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 510 | $155.57 | 35,285 (Direct) | View |
| 2020-02-17 Tax Withholding | 2020-02-19 4:33 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 944 | $241.5 | 33,158 (Direct) | View |
| 2020-02-24 Tax Withholding | 2020-02-26 4:32 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 2,898 | $239.23 | 26,626 (Direct) | View |
| 2020-05-06 Exercise | 2020-05-08 4:19 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO | 1,564 | $187.53 | 26,626 (Direct) | View |
| 2020-05-06 Exercise | 2020-05-08 4:19 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO | 510 | $155.57 | 26,626 (Direct) | View |
| 2020-05-06 Exercise | 2020-05-08 4:19 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO | 1,564 | $187.53 | 26,626 (Direct) | View |
| 2020-05-06 Exercise | 2020-05-08 4:19 pm | N/A 2028-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO | 510 | $155.57 | 26,626 (Direct) | View |
| 2020-08-06 Exercise | 2020-08-10 4:19 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO | 1,564 | $187.53 | 26,626 (Direct) | View |
| 2020-08-06 Exercise | 2020-08-10 4:19 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO | 509 | $155.57 | 26,626 (Direct) | View |
| 2020-08-06 Exercise | 2020-08-10 4:19 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO | 1,564 | $187.53 | 26,626 (Direct) | View |
| 2020-08-06 Exercise | 2020-08-10 4:19 pm | N/A 2028-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO | 509 | $155.57 | 26,626 (Direct) | View |